• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Acute band-shaped keratopathy after intraocular fibrinolysis with recombinant tissue plasminogen activator (rt-PA)].

作者信息

Althaus C, Schelle C, Sundmacher R

机构信息

Augenklinik, Heinrich-Heine-Universität Düsseldorf.

出版信息

Klin Monbl Augenheilkd. 1996 Nov;209(5):318-21. doi: 10.1055/s-2008-1035327.

DOI:10.1055/s-2008-1035327
PMID:9044983
Abstract

BACKGROUND

Intraocular fibrinolysis with recombinant tissue-plasminogen activator (rt-PA) in patients with severe fibrin reactions following anterior segment surgery is widely accepted because of the low complication rate.

CASES

We present two eyes of two patients developing acute bandkeratopathy within the first week after intraocular rt-PA fibrinolysis (10 mg/100 ml). In the first patient, calcium deposition occurred inferiorly of the optic axis without visual impairment. In the second patient, a dense bandkeratopathy reaching from limbus to limbus developed, with a severe decrease of vision. A corneal abrasion together with the chelating agent disodium ethylene diamine tetra-acetate (EDTA) 0.5% in neutral solution led only to an incomplete resolution of the depositions.

CONCLUSIONS

Acute development of a bandkeratopathy is very rare. Several risk factors are identified so far, e.g. the use of phosphate containing eye drops. Their interactions and the possible pathomechanism are discussed in detail. The close coincidence of intraocular rt-PA fibrinolysis and acute band-keratopathy in our two patients is in favor of an at least additive causative role of rt-PA fibrinolysis. Therefore, the indication should be limited to severe fibrin reactions and local application of phosphate containing drugs should be avoided.

摘要

相似文献

1
[Acute band-shaped keratopathy after intraocular fibrinolysis with recombinant tissue plasminogen activator (rt-PA)].
Klin Monbl Augenheilkd. 1996 Nov;209(5):318-21. doi: 10.1055/s-2008-1035327.
2
Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.重组纤溶酶原激活剂在眼内纤维蛋白溶解中的临床应用。
Ger J Ophthalmol. 1992;1(5):354-60.
3
[Band-like keratopathy after treatment of postoperative fibrin reaction with tissue plasminogen activator].
Klin Monbl Augenheilkd. 1996 Jul;209(1):43-6. doi: 10.1055/s-2008-1035276.
4
[Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].玻璃体切除术后用组织型纤溶酶原激活剂治疗眼内纤维蛋白形成
Zhonghua Yan Ke Za Zhi. 1995 Jul;31(4):255-8.
5
Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.组织型纤溶酶原激活剂用于治疗白内障手术后的眼内纤维蛋白膜。
Ger J Ophthalmol. 1995 Mar;4(2):75-9.
6
Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
J Cataract Refract Surg. 1999 Mar;25(3):357-62. doi: 10.1016/s0886-3350(99)80083-2.
7
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.体外凝块溶解作为血栓对纤维蛋白溶解抵抗的潜在指标——在健康受试者中的研究及其与血液纤溶参数的相关性
Thromb Haemost. 1997 Apr;77(4):725-9.
8
Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).大剂量组织型纤溶酶原激活剂及血浆半衰期延长的杂交纤溶酶原激活剂(K2tu-PA:CGP 42935)的溶栓和出血作用
Thromb Haemost. 1993 Aug 2;70(2):294-300.
9
[Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].
Ophthalmologe. 1996 Feb;93(1):49-53.
10
Life-threatening anaphylactoid shock caused by recombinant tissue plasminogen activator.由重组组织型纤溶酶原激活剂引起的危及生命的过敏性休克。
Am J Emerg Med. 2012 Jan;30(1):253.e1-2. doi: 10.1016/j.ajem.2010.10.005. Epub 2010 Dec 15.

引用本文的文献

1
EDTA chelation for symptomatic band keratopathy: results and recurrence.EDTA 螯合治疗症状性带状角膜病变:结果和复发。
Eye (Lond). 2018 Jan;32(1):26-31. doi: 10.1038/eye.2017.264. Epub 2017 Dec 1.
2
Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery.前房内注射重组组织型纤溶酶原激活剂治疗白内障手术后炎性膜后发生的人工晶状体混浊
J Ophthalmol. 2015;2015:975075. doi: 10.1155/2015/975075. Epub 2015 Mar 18.
3
Recombinant tissue plasminogen activator following paediatric cataract surgery.
小儿白内障手术后使用重组组织型纤溶酶原激活剂
Br J Ophthalmol. 2000 Sep;84(9):983-6. doi: 10.1136/bjo.84.9.983.